Medistem's IPO

Medistem raised a round of funding on December 15, 2006. Investors include Public.

Medistem, Inc. is developing ERC-124, a universal stem cell product derived from the endometrium. ERC-124 possesses specialized abilities to stimulate new blood vessel formation and can differentiate…

Articles about Medistem's IPO: